Industry: Machinery & Equipment
Published Date: 2026-01-31
Pages: 107 Pages
Report ld: 5827604
Request Sample
Customized Report
The global market for Non-invasive Breathalyzer was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Non-invasive Breathalyzer cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Non-invasive Breathalyzer was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Non-invasive Breathalyzer was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Non-invasive Breathalyzer was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Non-invasive Breathalyzer market include Akers Biosciences, Inc., Philips Healthcare, OrSense, MediWise Ltd., Medtronic Plc., Abbott Laboratories, GE Healthcare, Nemaura Medical, Inc., Integrity Applications Inc., etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Non-invasive Breathalyzer, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Non-invasive Breathalyzer market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Non-invasive Breathalyzer.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Non-invasive Breathalyzer manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Non-invasive Breathalyzer sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Non-invasive Breathalyzer sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Non-invasive Breathalyzer Product Introduction
1.2 Global Non-invasive Breathalyzer Market Size Forecast
1.2.1 Global Non-invasive Breathalyzer Sales Value (2021–2032)
1.2.2 Global Non-invasive Breathalyzer Sales Volume (2021–2032)
1.2.3 Global Non-invasive Breathalyzer Sales Price (2021–2032)
1.3 Non-invasive Breathalyzer Market Trends & Drivers
1.3.1 Non-invasive Breathalyzer Industry Trends
1.3.2 Non-invasive Breathalyzer Market Drivers & Opportunities
1.3.3 Non-invasive Breathalyzer Market Challenges
1.3.4 Non-invasive Breathalyzer Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-invasive Breathalyzer Players Revenue Ranking (2025)
2.2 Global Non-invasive Breathalyzer Revenue by Company (2021–2026)
2.3 Global Non-invasive Breathalyzer Sales Volume Ranking of Players (2025)
2.4 Global Non-invasive Breathalyzer Sales Volume by Company (2021–2026)
2.5 Global Non-invasive Breathalyzer Average Price by Company (2021–2026)
2.6 Key Manufacturers Non-invasive Breathalyzer Manufacturing Base and Headquarters
2.7 Key Manufacturers Non-invasive Breathalyzer Product Offerings
2.8 Key Manufacturers Start of Mass Production of Non-invasive Breathalyzer
2.9 Non-invasive Breathalyzer Market Competitive Analysis
2.9.1 Non-invasive Breathalyzer Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-invasive Breathalyzer Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-invasive Breathalyzer revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Non-invasive Breathalyzer Market Classification
3.1 Introduction by Type
3.1.1 Breathalyzers
3.1.2 Glucose Monitors
3.1.3 Blood Analyses Monitors
3.1.4 Others
3.1.5 Global Non-invasive Breathalyzer Sales Value by Type
3.1.5.1 Global Non-invasive Breathalyzer Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Non-invasive Breathalyzer Sales Value, by Type (2021–2032)
3.1.5.3 Global Non-invasive Breathalyzer Sales Value, by Type (%), 2021–2032
3.1.6 Global Non-invasive Breathalyzer Sales Volume by Type
3.1.6.1 Global Non-invasive Breathalyzer Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Non-invasive Breathalyzer Sales Volume, by Type (2021–2032)
3.1.6.3 Global Non-invasive Breathalyzer Sales Volume, by Type (%), 2021–2032
3.1.7 Global Non-invasive Breathalyzer Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Homecare Settings
4.1.3 Others
4.2 Global Non-invasive Breathalyzer Sales Value by Application
4.2.1 Global Non-invasive Breathalyzer Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Non-invasive Breathalyzer Sales Value, by Application (2021–2032)
4.2.3 Global Non-invasive Breathalyzer Sales Value, by Application (%), 2021–2032
4.3 Global Non-invasive Breathalyzer Sales Volume by Application
4.3.1 Global Non-invasive Breathalyzer Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Non-invasive Breathalyzer Sales Volume, by Application (2021–2032)
4.3.3 Global Non-invasive Breathalyzer Sales Volume, by Application (%), 2021–2032
4.4 Global Non-invasive Breathalyzer Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Non-invasive Breathalyzer Sales Value by Region
5.1.1 Global Non-invasive Breathalyzer Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Non-invasive Breathalyzer Sales Value by Region (2021–2026)
5.1.3 Global Non-invasive Breathalyzer Sales Value by Region (2027–2032)
5.1.4 Global Non-invasive Breathalyzer Sales Value by Region (%), 2021–2032
5.2 Global Non-invasive Breathalyzer Sales Volume by Region
5.2.1 Global Non-invasive Breathalyzer Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Non-invasive Breathalyzer Sales Volume by Region (2021–2026)
5.2.3 Global Non-invasive Breathalyzer Sales Volume by Region (2027–2032)
5.2.4 Global Non-invasive Breathalyzer Sales Volume by Region (%), 2021–2032
5.3 Global Non-invasive Breathalyzer Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Non-invasive Breathalyzer Sales Value, 2021–2032
5.4.2 North America Non-invasive Breathalyzer Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Non-invasive Breathalyzer Sales Value, 2021–2032
5.5.2 Europe Non-invasive Breathalyzer Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Non-invasive Breathalyzer Sales Value, 2021–2032
5.6.2 Asia Pacific Non-invasive Breathalyzer Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Non-invasive Breathalyzer Sales Value, 2021–2032
5.7.2 South America Non-invasive Breathalyzer Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-invasive Breathalyzer Sales Value, 2021–2032
5.8.2 Middle East & Africa Non-invasive Breathalyzer Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-invasive Breathalyzer Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Non-invasive Breathalyzer Sales Value and Sales Volume
6.2.1 Key Countries/Regions Non-invasive Breathalyzer Sales Value, 2021–2032
6.2.2 Key Countries/Regions Non-invasive Breathalyzer Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Non-invasive Breathalyzer Sales Value, 2021–2032
6.3.2 United States Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Non-invasive Breathalyzer Sales Value, 2021–2032
6.4.2 Europe Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Non-invasive Breathalyzer Sales Value, 2021–2032
6.5.2 China Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.5.3 China Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Non-invasive Breathalyzer Sales Value, 2021–2032
6.6.2 Japan Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Non-invasive Breathalyzer Sales Value, 2021–2032
6.7.2 South Korea Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Non-invasive Breathalyzer Sales Value, 2021–2032
6.8.2 Southeast Asia Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Non-invasive Breathalyzer Sales Value, 2021–2032
6.9.2 India Non-invasive Breathalyzer Sales Value by Type (%), 2025 vs 2032
6.9.3 India Non-invasive Breathalyzer Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Akers Biosciences, Inc.
7.1.1 Akers Biosciences, Inc. Company Information
7.1.2 Akers Biosciences, Inc. Introduction and Business Overview
7.1.3 Akers Biosciences, Inc. Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Akers Biosciences, Inc. Non-invasive Breathalyzer Product Offerings
7.1.5 Akers Biosciences, Inc. Recent Developments
7.2 Philips Healthcare
7.2.1 Philips Healthcare Company Information
7.2.2 Philips Healthcare Introduction and Business Overview
7.2.3 Philips Healthcare Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Philips Healthcare Non-invasive Breathalyzer Product Offerings
7.2.5 Philips Healthcare Recent Developments
7.3 OrSense
7.3.1 OrSense Company Information
7.3.2 OrSense Introduction and Business Overview
7.3.3 OrSense Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 OrSense Non-invasive Breathalyzer Product Offerings
7.3.5 OrSense Recent Developments
7.4 MediWise Ltd.
7.4.1 MediWise Ltd. Company Information
7.4.2 MediWise Ltd. Introduction and Business Overview
7.4.3 MediWise Ltd. Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 MediWise Ltd. Non-invasive Breathalyzer Product Offerings
7.4.5 MediWise Ltd. Recent Developments
7.5 Medtronic Plc.
7.5.1 Medtronic Plc. Company Information
7.5.2 Medtronic Plc. Introduction and Business Overview
7.5.3 Medtronic Plc. Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Medtronic Plc. Non-invasive Breathalyzer Product Offerings
7.5.5 Medtronic Plc. Recent Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Company Information
7.6.2 Abbott Laboratories Introduction and Business Overview
7.6.3 Abbott Laboratories Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Abbott Laboratories Non-invasive Breathalyzer Product Offerings
7.6.5 Abbott Laboratories Recent Developments
7.7 GE Healthcare
7.7.1 GE Healthcare Company Information
7.7.2 GE Healthcare Introduction and Business Overview
7.7.3 GE Healthcare Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 GE Healthcare Non-invasive Breathalyzer Product Offerings
7.7.5 GE Healthcare Recent Developments
7.8 Nemaura Medical, Inc.
7.8.1 Nemaura Medical, Inc. Company Information
7.8.2 Nemaura Medical, Inc. Introduction and Business Overview
7.8.3 Nemaura Medical, Inc. Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Nemaura Medical, Inc. Non-invasive Breathalyzer Product Offerings
7.8.5 Nemaura Medical, Inc. Recent Developments
7.9 Integrity Applications Inc.
7.9.1 Integrity Applications Inc. Company Information
7.9.2 Integrity Applications Inc. Introduction and Business Overview
7.9.3 Integrity Applications Inc. Non-invasive Breathalyzer Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Integrity Applications Inc. Non-invasive Breathalyzer Product Offerings
7.9.5 Integrity Applications Inc. Recent Developments
8 Industry Chain Analysis
8.1 Non-invasive Breathalyzer Industrial Chain
8.2 Non-invasive Breathalyzer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Non-invasive Breathalyzer Sales Model
8.5.2 Sales Channels
8.5.3 Non-invasive Breathalyzer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Non-invasive Breathalyzer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-31
Pages: 130
USD 2900.00
(Single User License)
The global Non-invasive Breathalyzer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 136
USD 4900.00
(Single User License)
The global Non-invasive Breathalyzer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-13
Pages: 80
USD 4250.00
(Single User License)
The global market for Non-invasive Breathalyzer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-13
Pages: 97
USD 3950.00
(Single User License)
The global market for Non-invasive Breathalyzer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-13
Pages: 91
USD 2900.00
(Single User License)
The global Non-invasive Breathalyzer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-14
Pages: 98
USD 4900.00
(Single User License)
The global market for Non-invasive Breathalyzer was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-13
Pages: 95
USD 3950.00
(Single User License)
The global Non-invasive Breathalyzer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-31
Pages: 130
The global Non-invasive Breathalyzer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 136
The global Non-invasive Breathalyzer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 80
The global market for Non-invasive Breathalyzer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 97
The global market for Non-invasive Breathalyzer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-13
Pages: 91
The global Non-invasive Breathalyzer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-14
Pages: 98
The global market for Non-invasive Breathalyzer was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-13
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now